Vir Biotechnology Inc (NASDAQ: VIR) kicked off on Tuesday, down -0.18% from the previous trading day, before settling in for the closing price of $5.43. Over the past 52 weeks, VIR has traded in a range of $4.32-$14.45.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 55.77% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 16.37%. With a float of $89.08 million, this company’s outstanding shares have now reached $138.06 million.
In an organization with 408 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 68.7%, operating margin of -3081.35%, and the pretax margin is -2950.89%.
Vir Biotechnology Inc (VIR) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 35.56%, while institutional ownership is 53.56%. The most recent insider transaction that took place on Jun 10 ’25, was worth 273,885. Before that another transaction happened on Jun 09 ’25, when Company’s Former Director proposed sale 50,000 for $5.41, making the entire transaction worth $270,590.
Vir Biotechnology Inc (VIR) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 16.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.19% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Take a look at Vir Biotechnology Inc’s (VIR) current performance indicators. Last quarter, stock had a quick ratio of 6.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 35.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.22, a number that is poised to hit -0.74 in the next quarter and is forecasted to reach -3.08 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Let’s dig in a bit further. During the last 5-days, its volume was 1.2 million. That was inferior than the volume of 1.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 86.00%. Additionally, its Average True Range was 0.31.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 15.56%, which indicates a significant decrease from 81.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.42% in the past 14 days, which was lower than the 63.89% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.43, while its 200-day Moving Average is $7.58.
